MedTrace Logo

Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis

NCT01246518 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2012-10-25

No results posted yet for this study

Summary

Onychomycosis is a fungal infection that affects fingernails and/or toenails.

The purpose of this trial is to investigate if MOB015 is effective and safe for treatment of patients with fungal infection of the toenails.

Conditions

  • Onychomycosis

Interventions

DRUG

MOB015

Arm 1; MOB015 once a day for 3 months. Arm 2; MOB015 once a day for 9 months.

Sponsors & Collaborators

  • Moberg Pharma AB

    lead INDUSTRY

Principal Investigators

  • Jan Faergemann, MD, PhD · Dept. of Dermatology, Sahlgrenska University Hospital, Gothenburg, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Sweden

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01246518 on ClinicalTrials.gov